
FDA approves twice-yearly injectable lenacapavir for PrEP
By Jessica Bloome, MD, MPH On June 18th, the FDA approved the latest medication for HIV prevention – long-acting injectable lenacapavir (LEN), a subcutaneous injection administered every 6…
Capacity-Building Assistance: Services & Resources that have been instrumental in HIV prevention from the San Francisco Department of Public Health.
If you already know what you need, please submit a request in the CDC's CBA Tracking System (CTS).